American Association for Cancer Research (AACR) shared a post on LinkedIn:
“Crystal Mackall and Carl June took the stage on Day 3 of AACRIO25, unveiling cutting-edge approaches to improve CAR T-cell therapies. From tri-specific CARs to IL-9 signaling, their insights could enable major immunotherapy advances for solid tumors.
Read more on the AACR Blog.”
More posts featuring AACR.